Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration‐resistant prostate cancer cells via altering androgen receptor‐lectin‐like transcript 1 signals

多西紫杉醇 雄激素受体 前列腺癌 癌症研究 免疫疗法 细胞毒性 细胞培养 医学 生物 内科学 免疫系统 癌症 免疫学 体外 生物化学 遗传学
作者
Min Tang,Shenglin Gao,Lei Zhang,Bianjiang Liu,Jie Li,Zengjun Wang,Wei Zhang
出处
期刊:The Prostate [Wiley]
卷期号:80 (10): 742-752 被引量:10
标识
DOI:10.1002/pros.23988
摘要

Abstract Background Docetaxel is an effective first‐line chemotherapy agent used in the treatment of castration‐resistant prostate cancer (CRPC) patients. However, most times chemotherapy with docetaxel eventually fails due to the development of docetaxel resistance. Natural killer (NK) cells are the first line of defense against cancer and infections. NK cell function is determined by a delicate balance between signals received via activating and inhibitory receptors. The aim of this study is to explore whether the potential docetaxel‐resistant mechanism is associated with impaired NK cell cytotoxicity toward CRPC cells. Methods By performing MTT assay, we explored the role of docetaxel in regulating NK cells' cytotoxicity. Western blot and quantitative real‐time polymerase chain reaction analysis were used to measure messenger RNA and protein levels separately. Luciferase reporter assay and chromatin immunoprecipitation assay were performed to analyze the mechanism. Results We found that docetaxel could suppress the immunotherapy efficacy of NK cells toward CRPC cells via the androgen receptor (AR)‐lectin‐like transcript 1 (LLT1) signals in vitro. Analysis of the mechanism revealed that docetaxel functioned through increasing AR to upregulate LLT1 expression in CRPC cells. AR transcriptionally activated LLT1 expression by binding to its promoter region. Furthermore, targeting AR with ASC‐J9 or blocking LL1 by anti‐human LLT1 monoclonal antibody could reverse the suppressive effect of docetaxel on the immunotherapy efficacy of NK cells toward CRPC cells. Conclusions We concluded that chemotherapy agent docetaxel could increase AR that transcriptionally regulated the expression of NK inhibitory ligand LLT1 on CRPC cells. An increase of LL1 may further suppress the immunological efficacy of NK cells to kill CRPC cells. Additionally, targeting AR or blocking LL1 could enhance the immunotherapy efficacy of NK cells toward CRPC cells which might be considered as a new therapeutic option for the prevention or treatment of docetaxel resistance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage的应助被HouShipeng采纳,获得10
1秒前
念烟发布了新的文献求助10
2秒前
阔达的糖豆完成签到 ,获得积分10
2秒前
哈哈哈哈哈完成签到 ,获得积分10
3秒前
Orange的应助被科研通管家采纳,获得10
6秒前
Jasper的应助被科研通管家采纳,获得10
6秒前
充电宝的应助被TT采纳,获得10
6秒前
FashionBoy的应助被科研通管家采纳,获得10
6秒前
彭于晏的应助被科研通管家采纳,获得10
7秒前
北极光完成签到,获得积分10
7秒前
传奇3的应助被科研通管家采纳,获得10
7秒前
爆米花的应助被科研通管家采纳,获得10
7秒前
我是谁的应助被科研通管家采纳,获得20
7秒前
7秒前
7秒前
7秒前
共享精神的应助被科研通管家采纳,获得10
7秒前
小二郎的应助被科研通管家采纳,获得10
7秒前
丘比特的应助被科研通管家采纳,获得10
8秒前
8秒前
赘婿的应助被科研通管家采纳,获得10
8秒前
8秒前
香蕉觅云的应助被科研通管家采纳,获得20
8秒前
念烟完成签到,获得积分10
9秒前
9秒前
9秒前
9秒前
11秒前
研友_LBorkn完成签到,获得积分10
12秒前
12秒前
CarryLJR发布了新的文献求助10
12秒前
13秒前
HouShipeng发布了新的文献求助10
13秒前
13秒前
TEDDY发布了新的文献求助10
13秒前
楠楠发布了新的文献求助10
13秒前
ubless607的应助被Gp1983采纳,获得100
13秒前
zheng发布了新的文献求助10
13秒前
李健的应助被菠萝蜜采纳,获得30
14秒前
哈哈就是你哦完成签到,获得积分20
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188380
求助须知:如何正确求助?哪些是违规求助? 9576202
关于积分的说明 21846057
捐赠科研通 7786438
什么是DOI,文献DOI怎么找? 3435307
关于科研通互助平台的介绍 2559604
邀请新用户注册赠送积分活动 2482312